CatalystWireBeta

Form 8 (DD) - Futura Medical

In brief · summary, not quotable

Kenneth James, an Executive Director of Futura Medical PLC, disclosed dealings on September 25, 2026, resulting in a holding of 3,299,501 relevant securities, representing 0.22% of the class. This disclosure was made on September 29, 2026, in accordance with Rule 8 of the Takeover Code, and no other parties to the offer were involved in these specific disclosures.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your FUM notes

KEY INFORMATION

(a) Full name of discloser:Kenneth James
(d) Status of person making the disclosure: e.g. offeror, offeree, person acting in concert with the offeror/offeree (specify name of offeror/offeree)Executive Director
(e) Date dealing undertaken:25 September 2026
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
Class of relevant security:
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:3,299,5010.22
  • Cash-settled derivatives:
  • Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL:3,299,5010.22

All interests and all short positions should be disclosed.

  • Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

DEALINGS BY THE PERSON MAKING THE DISCLOSURE

The currency of all prices and other monetary amounts should be stated.

Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
  • Cash-settled derivative transactions
  • Stock-settled derivative transactions (including options)
  • Writing, selling, purchasing or varying
  • Exercise
  • Other dealings (including subscribing for new securities)
  • OTHER INFORMATION
  • Indemnity and other dealing arrangements
  • Agreements, arrangements or understandings relating to options or derivatives
  • Attachments

Are any Supplemental Forms attached?

Supplemental Form 8 (Open Positions)NO
Supplemental Form 8 (SBL)NO
Date of disclosure:29 September 2026

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note